Tonya R Kaltenbach, MD
Gastroenterology · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 12
- 2 carriers
- Office
- 1
Offices
1 location · Regents of the University of California · 706 clinicians in this group
Hospitals listed: UCSF Medical Center. That is not proof they admit you there this week.
Plans that list them
12 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Kaltenbach’s office at (415) 476-4029 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
12 of 12 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence A81539 · Current
Licensed to practise in California · since 2003 · expires 2029-01-31 · Jefferson Medical College of Thomas Jefferson University.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- UCSF Medical CenterSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of University of California Health, which runs 12 hospitalsHome of UCSF Helen Diller Family Comprehensive Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 81% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 4.9 (3.79 to 6.02) · 7,590 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 12.8 (11.3 to 14.4) · 2,019 cases, Jan 2024 – Dec 2024Better than the national rate — Death rate among surgical inpatients with serious treatable complications: 139.4 (110.22 to 168.58) · 452 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.622, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.626, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.491, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.8 (0.7 to 1) · 2,336 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for UCSF Medical Center
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 3 better, 5 the same, 3 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.9 (3.79 to 6.02) · 7,590 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.8 (11.3 to 14.4) · 2,019 cases | Worse | Jan 2024 – Dec 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 139.4 (110.22 to 168.58) · 452 cases | Better | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.622 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.626 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.491 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.7 to 1) · 2,336 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.24 (0.58 to 1.9) · 4,689 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.05 (0.89 to 1.2) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.9 · 89 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.5 · 85 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.1 · 132 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.6 · 454 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 618 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 380 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.7 · 5,000 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.22 (0.06 to 0.38) · 15,965 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.05 to 0.35) · 17,859 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.85 (0 to 1.83) · 4,184 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2 (1.1 to 2.9) · 6,516 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.35 (4.49 to 10.21) · 3,989 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5 (3.22 to 6.77) · 4,087 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.95 (0.74 to 3.15) · 2,034 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.95 (0.63 to 1.28) · 15,431 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 399 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.899 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.689 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.224 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16 · 156 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20 · 564 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 60.3 · 160 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -9.7 · 550 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 44.1 · 660 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 667 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (4.8 to 6.7) · 2,019 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6 · 421 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.5 · 53 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 107 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.9 (11.3 to 17.1) · 3,247 cases | No different | Jan 2022 – Dec 2024 |
What patients said (3,181 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 50% |
| "YES", patients would definitely recommend the hospital | 81% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$16,238
Medicare paid this office $16,238 for 57 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Removal of large bowel tissue using a flexible endoscope | 15 | $5,569 | $293 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 28 | $5,465 | $188 |
| Biopsy of large bowel using a flexible endoscope | 20 | $1,375 | $69 |
Procedures Medicare counted
| Colonoscopy | 54 | More than 65% of doctors who do this |
| Upper gastrointestinal (GI) endoscopy for acid reflux | 19 | More than 50% of doctors who do this |
Who their Medicare patients are
57 Original Medicare patients in 2024. Average age 73 · Women 53% · Also on Medicaid 19% · Health risk score 1.44. Above the middle of the specialty; the typical gastroenterology clinician is at 1.42.
Conditions among them: High blood pressure 61% · Cancer 37% · Diabetes 32% · Depression 25%.
The office billed $236,019, Medicare allowed $20,669 and paid $16,238; for 99 services of 16 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 57 | 99 | 73 | 1.44 | $236,019 | $16,238 |
| 2023 | 49 | 98 | 73 | 1.25 | $256,083 | $15,516 |
| 2022 | 35 | 64 | 71 | 1.27 | $156,643 | $10,651 |
| 2021 | 20 | 33 | 71 | 1.36 | $120,157 | $5,660 |
| 2020 | 20 | 37 | 72 | 1.12 | $160,475 | $6,425 |
| 2019 | 21 | 28 | 74 | 1.36 | $85,275 | $6,006 |
| 2018 | 30 | 72 | 74 | 0.87 | $30,295 | $8,286 |
| 2017 | 21 | 55 | 75 | 0.96 | $16,950 | $6,035 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 3 services
| Removal of large bowel tissue using a flexible endoscope | 24 | $7,416 | $297 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 27 | $4,911 | $175 |
| Biopsy of large bowel using a flexible endoscope | 18 | $1,148 | $52 |
2022: 3 services
| Removal of large bowel tissue using a flexible endoscope | 16 | $4,626 | $272 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 19 | $3,465 | $165 |
| Biopsy of large bowel using a flexible endoscope | 12 | $536 | $41 |
2021: 1 service
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 13 | $2,048 | $146 |
2020: 1 service
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 11 | $1,876 | $171 |
2019: 1 service
| Removal of large bowel tissue using a flexible endoscope | 12 | $3,628 | $302 |
2018: 3 services
| Destruction of polyp or growth of large bowel using a flexible endoscope | 13 | $3,657 | $229 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 14 | $2,454 | $164 |
| Injection beneath lining of large bowel using a flexible endoscope | 13 | $213 | $14 |
Money from drug and device companies
$121,172 in 2025
| 2025 | 5 | 99 | $104,694 | $121,172 |
| 2024 | 4 | 59 | $49,580 | $73,188 |
| 2023 | 1 | 25 | $12,777 | $24,182 |
| 2021 | 2 | 2 | $5,250 | $5,250 |
| 2020 | 2 | 2 | $1,384 | $1,443 |
| 2019 | 2 | 47 | $27,368 | $43,633 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Olympus | Gastrointestinal Videoscope | $78,966 | 50 payments
|
| Boston Scientific | General - Therapies | $29,730 | 33 payments
|
| Olympus America | None | $9,531 | 2 payments
|
| Olympus Medical Systems | Evis Exera III Colonovideoscope | $1,601 | 6 payments
|
| Olympus Corporation of the Americas | Evis Exera III Colonovideoscope | $1,345 | 8 payments
|
See all 99 published payments
| Olympus America | Travel · 2025-12-09 | None | $35 |
| Olympus America | Travel · 2025-12-09 | None | $9,496 |
| Boston Scientific | Consulting · 2025-12-04 | General - Therapies | $3,000 |
| Boston Scientific | Meals · 2025-12-04 | General - Therapies | $41 |
| Boston Scientific | Consulting · 2025-12-04 | General - Therapies | $7,500 |
| Boston Scientific | Travel · 2025-12-04 | General - Therapies | $114 |
| Olympus Medical Systems | Travel · 2025-12-04 | Evis Exera III Colonovideoscope | $36 |
| Olympus Medical Systems | Travel · 2025-12-04 | Evis Exera III Colonovideoscope | $2 |
| Olympus Medical Systems | Travel · 2025-12-04 | Evis Exera III Colonovideoscope | $2 |
| Olympus Medical Systems | Consulting · 2025-12-04 | Evis Exera III Colonovideoscope | $1,340 |
| Olympus Medical Systems | Consulting · 2025-12-04 | Evis Exera III Colonovideoscope | $111 |
| Olympus Medical Systems | Consulting · 2025-12-04 | Evis Exera III Colonovideoscope | $111 |
| Boston Scientific | Meals · 2025-11-05 | General - Endochoice | $30 |
| Boston Scientific | Travel · 2025-11-05 | General - Endochoice | $133 |
| Boston Scientific | Meals · 2025-11-04 | General - Therapies | $7 |
| Boston Scientific | Meals · 2025-11-04 | General - Endochoice | $176 |
| Boston Scientific | Travel · 2025-11-04 | General - Endochoice | $184 |
| Boston Scientific | Travel · 2025-11-04 | General - Endochoice | $180 |
| Boston Scientific | Travel · 2025-11-03 | General - Endochoice | $184 |
| Boston Scientific | Travel · 2025-11-03 | General - Endochoice | $182 |
| Boston Scientific | Travel · 2025-11-03 | General - Endochoice | $431 |
| Olympus | Travel · 2025-09-12 | None | $32 |
| Olympus | Travel · 2025-09-12 | None | $114 |
| Olympus | Travel · 2025-09-12 | None | $28 |
| Olympus | Consulting · 2025-09-12 | None | $670 |
| Olympus | Consulting · 2025-09-12 | None | $7,370 |
| Olympus | Consulting · 2025-09-12 | None | $3,350 |
| Olympus | Consulting · 2025-09-12 | None | $2,680 |
| Olympus | Consulting · 2025-09-12 | None | $2,680 |
| Olympus | Consulting · 2025-09-12 | None | $1,340 |
| Olympus | Consulting · 2025-09-12 | None | $670 |
| Olympus | Consulting · 2025-09-12 | None | $503 |
| Olympus | Consulting · 2025-09-12 | None | $335 |
| Olympus | Consulting · 2025-09-12 | None | $1,340 |
| Olympus | Consulting · 2025-09-12 | None | $335 |
| Olympus | Consulting · 2025-09-12 | None | $168 |
| Olympus | Consulting · 2025-09-12 | None | $670 |
| Olympus | Consulting · 2025-09-12 | None | $670 |
| Olympus | Consulting · 2025-09-12 | None | $1,340 |
| Olympus | Consulting · 2025-09-12 | None | $670 |
| Olympus | Consulting · 2025-09-12 | None | $670 |
| Olympus | Consulting · 2025-09-12 | None | $168 |
| Olympus Corporation of the Americas | Meals · 2025-06-21 | Evis Exera III Colonovideoscope | $54 |
| Olympus Corporation of the Americas | Meals · 2025-06-21 | Evis Exera III Colonovideoscope | $27 |
| Olympus Corporation of the Americas | Meals · 2025-06-21 | Evis Exera III Colonovideoscope | $53 |
| Olympus Corporation of the Americas | Meals · 2025-06-20 | Evis Exera III Colonovideoscope | $54 |
| Olympus Corporation of the Americas | Meals · 2025-06-20 | Evis Exera III Colonovideoscope | $41 |
| Olympus Corporation of the Americas | Meals · 2025-06-20 | Evis Exera III Colonovideoscope | $69 |
| Olympus Corporation of the Americas | Travel · 2025-06-19 | Evis Exera III Colonovideoscope | $906 |
| Olympus Corporation of the Americas | Meals · 2025-06-19 | Evis Exera III Colonovideoscope | $142 |
| Olympus | Travel · 2025-05-21 | Evis Exera III Colonovideoscope | $35 |
| Olympus | Travel · 2025-05-19 | Evis Exera III Colonovideoscope | $35 |
| Olympus | Travel · 2025-05-19 | Evis Exera III Colonovideoscope | $692 |
| Olympus | Consulting · 2025-05-05 | None | $1,340 |
| Olympus | Consulting · 2025-05-05 | None | $1,340 |
| Olympus | Travel · 2025-03-18 | None | $116 |
| Olympus | Meals · 2025-03-18 | None | $37 |
| Olympus | Consulting · 2025-03-18 | None | $7,705 |
| Olympus | Consulting · 2025-03-18 | None | $4,020 |
| Olympus | Consulting · 2025-03-18 | None | $670 |
| Olympus | Consulting · 2025-03-18 | None | $4,020 |
| Olympus | Consulting · 2025-03-18 | None | $4,020 |
| Boston Scientific | Consulting · 2025-03-13 | General - Therapies | $750 |
| Boston Scientific | Meals · 2025-03-12 | General - Therapies | $74 |
| Boston Scientific | Paid to speak or teach · 2025-02-27 | General - Therapies | $500 |
| Boston Scientific | Paid to speak or teach · 2025-02-27 | General - Therapies | $1,500 |
| Boston Scientific | Travel · 2025-02-27 | General - Therapies | $111 |
| Boston Scientific | Paid to speak or teach · 2025-02-27 | General - Therapies | $8,000 |
| Boston Scientific | Paid to speak or teach · 2025-02-27 | General - Therapies | $3,000 |
| Boston Scientific | Meals · 2025-02-27 | General - Therapies | $33 |
| Boston Scientific | Paid to speak or teach · 2025-02-27 | General - Therapies | $1,500 |
| Boston Scientific | Consulting · 2025-02-27 | General - Therapies | $500 |
| Olympus | Meals · 2025-02-07 | None | $12 |
| Olympus | Meals · 2025-01-26 | Gastrointestinal Videoscope | $14 |
| Olympus | Meals · 2025-01-26 | Gastrointestinal Videoscope | $7 |
| Olympus | Travel · 2025-01-26 | Gastrointestinal Videoscope | $110 |
| Olympus | Meals · 2025-01-25 | Gastrointestinal Videoscope | $14 |
| Olympus | Meals · 2025-01-25 | Gastrointestinal Videoscope | $8 |
| Olympus | Meals · 2025-01-25 | Gastrointestinal Videoscope | $84 |
| Olympus | Travel · 2025-01-24 | Gastrointestinal Videoscope | $86 |
| Olympus | Travel · 2025-01-24 | Gastrointestinal Videoscope | $422 |
| Olympus | Meals · 2025-01-24 | Gastrointestinal Videoscope | $91 |
| Boston Scientific | Meals · 2025-01-19 | Overstitch Endoscopic Suturing System | $61 |
| Boston Scientific | Travel · 2025-01-18 | Overstitch Endoscopic Suturing System | $77 |
| Boston Scientific | Meals · 2025-01-18 | Overstitch Endoscopic Suturing System | $188 |
| Boston Scientific | Travel · 2025-01-17 | Overstitch Endoscopic Suturing System | $260 |
| Boston Scientific | Travel · 2025-01-17 | Overstitch Endoscopic Suturing System | $52 |
| Boston Scientific | Meals · 2025-01-17 | Overstitch Endoscopic Suturing System | $200 |
| Boston Scientific | Meals · 2025-01-17 | Overstitch Endoscopic Suturing System | $152 |
| Boston Scientific | Meals · 2025-01-17 | Apollo Esg Nxt System | $7 |
| Olympus | Consulting · 2025-01-17 | None | $2,680 |
| Olympus | Consulting · 2025-01-17 | None | $7,370 |
| Olympus | Consulting · 2025-01-17 | None | $4,690 |
| Olympus | Consulting · 2025-01-17 | None | $5,360 |
| Olympus | Consulting · 2025-01-17 | None | $4,020 |
| Olympus | Consulting · 2025-01-17 | None | $4,020 |
| Olympus | Travel · 2025-01-17 | None | $144 |
| Boston Scientific | Travel · 2025-01-16 | Overstitch Endoscopic Suturing System | $343 |
| Boston Scientific | Travel · 2025-01-16 | Overstitch Endoscopic Suturing System | $260 |
See earlier years (2024, 2023, 2021, 2020, 2019)
2024: $73,188
| Olympus | Evis Exera III Colonovideoscope | $69,762 | 48 payments
|
| Olympus Corporation of the Americas | Evis Exera III Colonovideoscope | $2,120 | 9 payments
|
| Olympus Medical Systems | None | $1,230 | 1 payment
|
| Boston Scientific | None | $76 | 1 payment
|
2023: $24,182
| Olympus Corporation of the Americas | Evis Exera III Duodenovideoscope | $24,182 | 25 payments
|
2021: $5,250
| Medtronic | None | $4,500 | 1 payment
|
| Intuitive Surgical | Da Vinci Surgical System | $750 | 1 payment
|
2020: $1,443
| Olympus | None | $1,384 | 1 payment
|
| Olympus Corporation of the Americas | Evis Exera | $59 | 1 payment
|
2019: $43,633
| Olympus Corporation of the Americas | Evis Exera | $28,406 | 35 payments
|
| Olympus | None | $15,227 | 12 payments
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Gyrus ACMI, Inc. · Evaluation of the Clinical Performance of An Investigational Real-Time Colorectal Polyp Clinical Decision Support Device (Cdsd) · 2023 | Their institution | $28,755 |
| Gyrus ACMI, Inc. · Evaluation of the Clinical Performance of An Investigational Real-Time Colorectal Polyp Clinical Decision Support Device (Cdsd) · 2021 | Their institution | $9,325 |
| Covidien LP · Barrx · 2019 | This clinician | $4,500 |
Professional record
- NPI
- 1578618419
- Licence
- CA A81539California A81539: Current · expires 2029-01-31
- Trained
- Jefferson Medical College of Thomas Jefferson University, 2001
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 174400000X (174400000X)
- Mailing address
- 3870 Jackson St, San Francisco, CA, 94118
- NPI first listed
- 2007-01-23
- NPI last updated
- 2015-12-31
This is when the NPI record was last certified, not a medical board exam.